NEOQ develops NeoTrak, an AI-powered wearable patch that non-invasively monitors newborns for jaundice, pneumonia, dehydration, and respiratory distress, enabling early and affordable care.
Founders
Ms.Saumyashree Swain
Medtech / Neonatal Health / Medical Device
The Problem:
High prevalence of health complications among premature and LBW infants; lack of trained specialists and missed/late diagnosis due to manual monitoring.
The Solution:
NeoTrak offers comprehensive, real-time analytics via a wearable patch, enabling early detection and intervention for critical neonatal conditions without relying on expensive or professional-only equipment.
Who Benefits?
- Neonatal ICUs (NICUs)
- Special Newborn Care Units (SNCUs)
- Hospitals in tier 2+ cities and rural areas
- Preterm and LBW infants
- Pediatricians and nursing staff
Key Achievements
- Prototypes tested and validated with live hospital data
- Secured NIDHI Prayas and Chunauti grants
- Patent filed for technology
- Ongoing clinical partnership and pilot deployments
Societal Impact
NeoTrak improves neonatal survival by enabling affordable, intuitive diagnostics and reducing time-to-care, particularly in resource-constrained settings.
Vision for the Future
Year 1:Clinical trials and CDSCO licensing
Year 2:Regional expansion and market entry (5,000+ devices)
Year 3:R&D for additional vital sign detection
Year 4:Patent portfolio and IP development
Year 5:Target 12,000+ hospitals and national pediatric care coverage
